Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study
Doravirine-based ART maintained virological suppression in PWH switching from etravirine-based ART, even in presence of prior NNRTI resistance. Its once-daily dosing, favourable safety profile, and minimal drug interactions support its use in long-term ART strategies.
Authors
- Claudine Duvivier (ORCID: https://orcid.org/0000-0001-5696-4173)
- Christine Katlama (ORCID: https://orcid.org/0000-0002-5093-4800)
- Clotilde Allavena (ORCID: https://orcid.org/0000-0003-1010-1270)
- Jade Ghosn (ORCID: https://orcid.org/0000-0003-2914-959X)
- Yasmine Dudoit
- Romain Palich (ORCID: https://orcid.org/0000-0003-0047-0101)
- A. Kaba (ORCID: https://orcid.org/0000-0002-6462-5742)
- Pierre Delobel (ORCID: https://orcid.org/0000-0002-2874-3581)
- Karine Lacombe (ORCID: https://orcid.org/0000-0001-8772-9029)
- Firouzé Bani‐Sadr (ORCID: https://orcid.org/0000-0001-8268-866X)
- Lambert Assoumou (ORCID: https://orcid.org/0000-0002-5547-1796)
- Pascal Puglièse
- Christia Palacios
- Duc Vu (ORCID: https://orcid.org/0009-0009-8785-2460)
- Olivier Robineau
- Cathia Soulié (ORCID: https://orcid.org/0009-0008-2032-4148)
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Délégation Paris 7 (FR)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Université Paris Cité (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Sorbonne Université (FR)
- Institut Necker Enfants Malades (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre Hospitalier Universitaire de Reims (FR)
- Centre Hospitalier de Tourcoing (FR)
- Centre d'Investigation Clinique de Nantes (FR)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
- Université de Reims Champagne-Ardenne (FR)
- Nantes Université (FR)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1093/jac/dkaf410
- Citations
- 1
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.40